UnitedHealth Group Inc (UNH) Shares Obtained by Abner Herrman & Brock LLC

UnitedHealth Group Inc (UNH) Shares Obtained by Abner Herrman & Brock LLC

Abner Herrman & Brock LLC raised its stake in UnitedHealth Group Inc (NYSE:UNH) by 7.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 43,226 shares of the healthcare conglomerate’s stock after purchasing an additional 2,872 shares during the period. UnitedHealth Group accounts for 2.0% of Abner Herrman & Brock LLC’s holdings, making the stock its 21st biggest holding. Abner Herrman & Brock LLC’s holdings in UnitedHealth Group were worth $10,768,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Capital International Investors increased its position in shares of UnitedHealth Group by 223.0% during the third quarter. Capital International Investors now owns 16,319,843 shares of the healthcare conglomerate’s stock worth $4,341,731,000 after acquiring an additional 11,267,910 shares in the last quarter. FMR LLC increased its position in shares of UnitedHealth Group by 5.1% during the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after acquiring an additional 2,981,233 shares in the last quarter. Rehmann Capital Advisory Group increased its position in shares of UnitedHealth Group by 26,088.2% during the third quarter. Rehmann Capital Advisory Group now owns 1,723,185 shares of the healthcare conglomerate’s stock worth $6,477,000 after acquiring an additional 1,716,605 shares in the last quarter. Vontobel Asset Management Inc. bought a new stake in shares of UnitedHealth Group during the second quarter worth about $404,980,000. Finally, Vanguard Group Inc. increased its position in shares of UnitedHealth Group by 1.6% during the third quarter. Vanguard Group Inc. now owns 69,342,549 shares of the healthcare conglomerate’s stock worth $18,447,892,000 after acquiring an additional 1,073,505 shares in the last quarter. 85.28% of the stock is owned by hedge funds and other institutional investors.

In other news, Director Richard T. Burke sold 6,090 shares of the business’s stock in a transaction that occurred on Wednesday, November 28th. The shares were sold at an average price of $281.72, for a total value of $1,715,674.80. Following the sale, the director now owns 1,711,584 shares of the company’s stock, valued at $482,187,444.48. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Kenneth Irwin Shine sold 163 shares of the business’s stock in a transaction that occurred on Friday, November 9th. The shares were sold at an average price of $274.83, for a total transaction of $44,797.29. The disclosure for this sale can be found here. 0.87% of the stock is owned by insiders.

UNH traded up $0.57 during midday trading on Friday, reaching $245.44. The company had a trading volume of 1,719,642 shares, compared to its average volume of 4,239,340. The company has a quick ratio of 0.69, a current ratio of 0.69 and a debt-to-equity ratio of 0.61. The stock has a market cap of $234.39 billion, a price-to-earnings ratio of 24.37, a PEG ratio of 1.23 and a beta of 0.88. UnitedHealth Group Inc has a 12-month low of $208.48 and a 12-month high of $287.94.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.30 by $0.11. The firm had revenue of $56.56 billion for the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a net margin of 5.71% and a return on equity of 23.62%. The company’s quarterly revenue was up 12.4% on a year-over-year basis. During the same period in the previous year, the company earned $2.66 earnings per share. As a group, sell-side analysts anticipate that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.

The business also recently announced a quarterly dividend, which was paid on Thursday, December 13th. Shareholders of record on Monday, December 3rd were paid a $0.90 dividend. This represents a $3.60 dividend on an annualized basis and a yield of 1.47%. The ex-dividend date of this dividend was Friday, November 30th. UnitedHealth Group’s payout ratio is 35.75%.

Several research firms recently weighed in on UNH. Zacks Investment Research upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $305.00 price target on the stock in a report on Friday, December 14th. BMO Capital Markets boosted their price target on shares of UnitedHealth Group to $310.00 and gave the stock an “outperform” rating in a report on Thursday, October 18th. Oppenheimer boosted their price target on shares of UnitedHealth Group from $276.00 to $295.00 and gave the stock an “outperform” rating in a report on Wednesday, October 17th. Finally, Piper Jaffray Companies boosted their price target on shares of UnitedHealth Group to $300.00 and gave the stock an “overweight” rating in a report on Wednesday, October 17th. One analyst has rated the stock with a hold rating and twenty-two have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus target price of $292.33.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Quiet Period

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).

Related posts

Leave a Comment